SCM
DXCM icon

Spyglass Capital Management’s DexCom DXCM Stock Holding History

Spyglass Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-2,056
Closed -$212K – 26
2020
Q3 		$212K Hold
2,056
– – 0.01% 26
2020
Q2 		$208K Sell
2,056
-271,884
-99% -$24.3M 0.01% 26
2020
Q1 		$18.4M Sell
273,940
-166,496
-38% -$10.4M 2.08% 24
2019
Q4 		$24.1M Buy
440,436
+55,832
+15% +$2.65M 3.09% 21
2019
Q3 		$14.3M Sell
384,604
-64,136
-14% -$2.49M 3.81% 12
2019
Q2 		$16.8M Buy
448,740
+82,628
+23% +$2.6M 5.31% 3
2019
Q1 		$10.9M Buy
366,112
+159,336
+77% +$5.6M 4.22% 12
2018
Q4 		$6.19M Buy
+206,776
New +$6.56M 4.64% 6

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Spyglass Capital Management's DXCM Position: Q4 2020 in Review

Spyglass Capital Management sold out of DexCom (DXCM) in Q4 2020, closing a stake of 2,056 shares — an estimated $212K sold.

Spyglass Capital Management first reported a position in DXCM in Q4 2018 and held it in 8 quarters. The position peaked at $24.1M in Q4 2019. 733 funds tracked by Wall St. Rank hold DXCM as of Q4 2020.

  • Spyglass Capital Management reported no remaining DexCom position as of Q4 2020 after selling out during the quarter.
  • Spyglass Capital Management sold 2,056 DexCom shares in Q4 2020, an estimated $212K.
  • Spyglass Capital Management first reported a position in DexCom in Q4 2018 and held it in 8 quarters.
  • Spyglass Capital Management's DexCom position peaked at $24.1M in Q4 2019.
  • 733 funds tracked by Wall St. Rank held DexCom as of Q4 2020.

Based on Spyglass Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.